South Korea's Samsung Biologics said on Monday that it had made an all-cash bid of 1.46 billion Swiss francs ($1.8 billion) for Switzerland's PolyPeptide Group.
馃張 Predicting 2026 fantasy 'league winners'
Michael F. Florio shares his players with breakout potential who could lead fantasy managers to titles in 2026.